Fortis Malar Hospitals Ltd. has showcased significant challenges in growth and profitability metrics compared to its peers. The company faces a steep decline in revenue, leading to an exceptionally high PE ratio, suggesting it is overvalued relative to its peers. Meanwhile, companies like Max Healthcare Institute and Global Health Ltd. demonstrate strong growth and reasonable valuations, indicating they are sector leaders and attractive for investment.

• • Fortis Malar Hospitals has negative revenue growth YoY and a high PE ratio of 307.86, indicating overvaluation.
• • Max Healthcare Institute and Global Health Ltd. exhibit strong revenue growth and reasonable valuation metrics, making them sector leaders.
• • Financially weak companies include Fortis Malar Hospitals due to high PE and negative revenue growth.